English Italiano Deutsch France

Welcome to Scapa

Scapa Group plc is a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets.  Scapa has a global footprint, with production sites in Asia, Europe and the US.

Our worldwide service and supply chain capabilities place us in an excellent position to partner with global customers.  We are focused on sustainable growth and innovation, improving the solutions for our customers by applying our knowledge and expertise in advanced material technology and process solutions.

We conduct our activities through two distinct and separate businesses: Healthcare and Industrial, each with its own focus and strategy.

Scapa Healthcare is a leading strategic outsource partner of choice in the Advanced Wound Care, Consumer Wellness, Medical Device Fixation and Drug Delivery markets. 

Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, via the two business models of Engineered Products and Commercial Products.

Find out more »

UK Modern Slavery Act - 2018
Toxic Reduction Plan 2011
Toxic Reduction Annual
Report 2018




Current share price: 207.50p   +4.00p


Annual Report 2019 and Notice of AGM
In accordance with AIM Rule 20, Scapa Group plc (AIM: SCPA) confirms that the Annual Report and Accounts for the year ended 31 March 2019, and the Notice of Annual General Meeting, are now available. Click here

Board Update
Scapa Group plc (AIM: SCPA) announces that further to the announcement on 21 May 2019, Heejae Chae has agreed to retract his intention to step down and will remain as Group Chief Executive of the Company to execute against the current strategy.   Click here

Notice of Termination of Material Contract
Scapa Group plc (AIM: SCPA) announces that on Friday 31 May after the market closed, Scapa received notice from ConvaTec Inc. Click here